Symbols

AUGX(Delisted)

Augmedix·NASDAQ

--(--)

Signals Analysis

Bullish signal 1

Bearish signal 1

Revenue Beats Expectation

EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About AUGX

Augmedix, Inc.

A leading provider of automated medical documentation solutions

Industry

Established Date

12/27/2018

Listing Date

10/26/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

1,430

Fiscal Year Ends

12-31

Website

www.augmedix.com

Security Type

Common stock

Office address

111 Sutter Street, Suite 1300, San Francisco, California 94104

Business

Introduction

Augmedix, Inc., was incorporated in Delaware on December 27, 2018. The company's mission is to re-humanize healthcare by enabling physicians to practice medicine patient-centered. The company's solutions help reduce the burden of medical record documentation so that doctors can focus on what they do best — patient care. The company is a provider of fully outsourced medical note documentation solutions that also provide clinical support to the US healthcare industry. The company provides software compatible with off-the-shelf mobile client devices, enabling clinicians to communicate with MDS. The company's MDS observes the clinician-patient interaction through audio/video and extracts the relevant medical elements of that interaction.

Company Financials

EPS

AUGX has released its 2024 Q2 earnings. EPS was reported at -0.16, versus the expected -0.13, missing expectations. The chart below visualizes how AUGX has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

AUGX has released its 2024 Q2 earnings report, with revenue of 13.66M, reflecting a YoY change of 26.75%, and net profit of -8.45M, showing a YoY change of -67.89%. The Sankey diagram below clearly presents AUGX's revenue sources and cost distribution.